SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/03/23 Aldeyra Therapeutics, Inc. S-8 11/03/23 4:118K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-8 Registration Statement - Securities for an HTML 50K Employee Benefit Plan 2: EX-5.1 Opinion of Counsel re: Legality HTML 8K 3: EX-23.1 Consent of Expert or Counsel HTML 5K 4: EX-FILING FEES Filing Fees HTML 15K
EX-23.1 |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-8 of our report dated March 9, 2023, relating to the consolidated financial statements of Aldeyra Therapeutics, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
/s/ BDO USA, P.C.
Boston, Massachusetts
BDO USA, P.C., a Virginia professional corporation, is the U.S. member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.
BDO is the brand name for the BDO network and for each of the BDO Member Firms.
This ‘S-8’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 11/3/23 | 10-Q | ||
3/9/23 | 10-K, 8-K, S-8 | |||
12/31/22 | 10-K, 10-K/A, ARS | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/07/24 Aldeyra Therapeutics, Inc. S-8 POS 3/07/24 1:30K Donnelley … Solutions/FA |